With the ability to be finely engineered to tackle the disease in different ways, nanoparticles hold huge potential when it comes to cancer treatment. Researchers at the Tokyo University of Science have now demonstrated a low-cost and highly promising form of this technology, using corn and water as a starting point for a novel "bionanoparticle" that suppresses tumor growth in mice.
We've seen nanoparticles developed to take the fight to cancer in many ways, from light-activated versions that rob cancerous cells of essential proteins, to versions that detect and track tumors months ahead of traditional imaging techniques, to name just a couple of examples. But these synthetic particles, which measure between one and 100 nanometers in size, are difficult and expensive to produce, leading the authors of this new study to investigate another possibility in the form of plant-derived nanoparticles.
These have emerged relatively recently as non-toxic and cost-effective tools for medical applications and drug delivery, and have the potential to target specific tissues and organs in the body. Exploring the possibilities in this area, the Tokyo University of Science team turned to one of our most commonly raised crops – corn.
"By controlling the physicochemical properties of nanoparticles, we can control their pharmacokinetics in the body; so, we wanted to explore the nanoparticulation of edible plants," said Professor Makiya Nishikawa of Tokyo University of Science, Japan. "Maize, or corn, is produced in large quantities worldwide in its native form as well as in its genetically modified forms. That is why we selected it for our study."
The experiments involved creating a mixture of super sweet corn and water, with this corn juice then centrifuged at high speed and filtered through a syringe with an opening of 0.45 μm. These filtered samples where then ultracentrifuged, allowing the team to extract tiny corn-derived nanoparticles around 80 nanometers in diameter.
In testing out their new nanoparticles, the scientists found that they were taken up by a range of cells, including tumor cells derived from mice, and macrophage-like cells called RAW264.7. Describing the results as astounding, the team watched as their nanoparticles triggered an immune response and released a tumor-killing factor from the RAW264.7 cells. They also showed a high selectivity for the tumor cells, and ultimately, significantly inhibited their growth.
The corn-derived nanoparticles were then tested on mice with cancer, with the team injecting them directly into tumors on a daily basis. This again significantly suppressed tumor growth, and caused no serious side effects or weight loss.
"By optimizing nanoparticle properties and by combining them with anticancer drugs, we hope to devise safe and efficacious drugs for various cancers," said Nishikawa.
The research was published in the journal Scientific Reports.
Source: Tokyo University of Science
